Authors: MIDTVEDT K TAFJORD AB NORDAL KP DRAGANOV B EIDE TC HARTMAN A BERG KJ HOLDAAS H FAUCHALD P

Citation: K. Midtvedt et al., OKT3 IN STEROID-RESISTANT REJECTIONS IN RENAL-TRANSPLANT RECIPIENTS -2.5 MG VS 5.0 MG, Kidney international, 49(3), 1996, pp. 921-921

Authors: MIDTVEDT K TAFJORD AB HARTMANN A EIDE TC HOLDAAS H NORDAL KP DRAGANOV B SODAL G LEIVESTAD T FAUCHALD P

Citation: K. Midtvedt et al., HALF DOSE OF OKT3 IS EFFICIENT IN TREATMENT OF STEROID-RESISTANT RENAL-ALLOGRAFT REJECTION, Transplantation, 62(1), 1996, pp. 38-42

Authors: MIDTVEDT K TAFJORD AB NORDAL KP DRAGANOV B EIDE T HARTMANN A FAUCHALD P BERG KJ LEIVESTAD T HOLDAAS H

Citation: K. Midtvedt et al., OKT3, DOSES OF 2.5 MG VERSUS 5 MG IN STEROID-RESISTANT RENAL-ALLOGRAFT REJECTIONS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1106-1106